no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
|
Verstraeten, Thomas |
|
2008 |
26 |
51 |
p. 6630-6638 9 p. |
article |
2 |
Antigen delivery systems for veterinary vaccine development
|
Brun, Alejandro |
|
2008 |
26 |
51 |
p. 6508-6528 21 p. |
article |
3 |
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
|
Schulze, Kai |
|
2008 |
26 |
51 |
p. 6678-6684 7 p. |
article |
4 |
Apropos “Hepatitis A in Jerusalem—The exception that proves the rule?”
|
Arya, Subhash C. |
|
2008 |
26 |
51 |
p. 6494- 1 p. |
article |
5 |
A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge
|
Saxena, Sonal |
|
2008 |
26 |
51 |
p. 6592-6601 10 p. |
article |
6 |
Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008
|
Koulova, Anna |
|
2008 |
26 |
51 |
p. 6529-6541 13 p. |
article |
7 |
Editorial Board
|
|
|
2008 |
26 |
51 |
p. CO2- 1 p. |
article |
8 |
Effects of targeted fusion anti-caries DNA vaccine pGJA-P/VAX in rats with caries
|
Liu, Chang |
|
2008 |
26 |
51 |
p. 6685-6689 5 p. |
article |
9 |
Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine
|
Lee, Joo Sub |
|
2008 |
26 |
51 |
p. 6569-6576 8 p. |
article |
10 |
Government financing for health and specific national budget lines: The case of vaccines and immunization
|
Lydon, Patrick |
|
2008 |
26 |
51 |
p. 6727-6734 8 p. |
article |
11 |
Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model
|
Hagenaars, Niels |
|
2008 |
26 |
51 |
p. 6555-6563 9 p. |
article |
12 |
IgA response by oral infection with an attenuated Yersinia enterocolitica mutant: Implications for its use as oral carrier vaccine
|
Blanco, Helga M. |
|
2008 |
26 |
51 |
p. 6497-6502 6 p. |
article |
13 |
Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice
|
Renoux, Virginie M.G. |
|
2008 |
26 |
51 |
p. 6602-6607 6 p. |
article |
14 |
Introducing new vaccines in the poorest countries: What did we learn from the GAVI experience with financial sustainability?
|
Lydon, P. |
|
2008 |
26 |
51 |
p. 6706-6716 11 p. |
article |
15 |
In vitro search for alternative promoters to the human immediate early cytomegalovirus (IE-CMV) to express the G gene of viral haemorrhagic septicemia virus (VHSV) in fish epithelial cells
|
Ruiz, S. |
|
2008 |
26 |
51 |
p. 6620-6629 10 p. |
article |
16 |
Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
|
Guimarães-Walker, A. |
|
2008 |
26 |
51 |
p. 6671-6677 7 p. |
article |
17 |
Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals
|
Lima-Junior, J.C. |
|
2008 |
26 |
51 |
p. 6645-6654 10 p. |
article |
18 |
Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures
|
Jäkel, Anne |
|
2008 |
26 |
51 |
p. 6655-6663 9 p. |
article |
19 |
Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs
|
Manickam, R. |
|
2008 |
26 |
51 |
p. 6564-6568 5 p. |
article |
20 |
Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase
|
Suh, You S. |
|
2008 |
26 |
51 |
p. 6690-6698 9 p. |
article |
21 |
Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)
|
Harvey, Ruth |
|
2008 |
26 |
51 |
p. 6550-6554 5 p. |
article |
22 |
Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: Implications for rational design of typhoid fever vaccines
|
Ruan, Ping |
|
2008 |
26 |
51 |
p. 6639-6644 6 p. |
article |
23 |
Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults
|
Leroux-Roels, Isabel |
|
2008 |
26 |
51 |
p. 6614-6619 6 p. |
article |
24 |
Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey
|
Polat, Aziz |
|
2008 |
26 |
51 |
p. 6495-6496 2 p. |
article |
25 |
Strategies for financial sustainability of immunization programs: A review of the strategies from 50 national immunization program financial sustainability plans
|
Kamara, Lidija |
|
2008 |
26 |
51 |
p. 6717-6726 10 p. |
article |
26 |
The elusive search for an HIV vaccine—And what to do meanwhile
|
Lazarus, Jeffrey V. |
|
2008 |
26 |
51 |
p. 6491-6493 3 p. |
article |
27 |
The GAVI Financing Task Force: One model of partner collaboration
|
Milstien, Julie B. |
|
2008 |
26 |
51 |
p. 6699-6705 7 p. |
article |
28 |
Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: Final report
|
But, David Yiu-Kuen |
|
2008 |
26 |
51 |
p. 6587-6591 5 p. |
article |
29 |
Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies
|
De Filette, Marina |
|
2008 |
26 |
51 |
p. 6503-6507 5 p. |
article |
30 |
Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina
|
Maradei, Eduardo |
|
2008 |
26 |
51 |
p. 6577-6586 10 p. |
article |
31 |
Vaccine against infectious bovine keratoconjunctivitis: A new approach to optimize the production of highly piliated Moraxella bovis cells
|
Prieto, Claudia I. |
|
2008 |
26 |
51 |
p. 6542-6549 8 p. |
article |
32 |
Vitamin A supplements are well tolerated with the pentavalent vaccine
|
Newton, Sam |
|
2008 |
26 |
51 |
p. 6608-6613 6 p. |
article |
33 |
Yersinia enterocolitica Yop mutants as oral live carrier vaccines
|
Leibiger, Robert |
|
2008 |
26 |
51 |
p. 6664-6670 7 p. |
article |